UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seckle's syndrome. (a case report)

Journal of postgraduate medicine (Bombay), 1980-10, Vol.26 (4), p.273-274

1980

Volltextzugriff (PDF)

Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction

Journal of hepatology, 2018-10, Vol.69 (4), p.886-895

2018

Volltextzugriff (PDF)

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

The Lancet (British edition), 2021-03, Vol.397 (10277), p.892-901

2021

Volltextzugriff (PDF)

Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation

Neuropharmacology, 2017-10, Vol.125, p.376-385

2017

Volltextzugriff (PDF)

Perceived Neighborhood Racial Composition and Depressive Symptoms Among Black Americans Across Adulthood: Evaluating the Role of Psychosocial Risks and Resources

Journal of aging and health, 2023-10, Vol.35 (9), p.660-676

2023

Volltextzugriff (PDF)

Association of Syndemic Unhealthy Alcohol Use, Smoking, and Depressive Symptoms on Incident Cardiovascular Disease among Veterans With and Without HIV-Infection

AIDS and behavior, 2021-09, Vol.25 (9), p.2852-2862

2021

Volltextzugriff (PDF)

Identifying the identifiers: How iNaturalist facilitates collaborative, research-relevant data generation and why it matters for biodiversity science

Bioscience, 2023-08, Vol.73 (7), p.533-541

2023

Volltextzugriff (PDF)

Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8)

Clinical and experimental immunology, 2009-11, Vol.158 (2), p.246-256

2009

Volltextzugriff (PDF)

An open-label, multicenter, phase I study of ABBV-399 (telisotuzumab vedotin, teliso-V) as monotherapy (T) and in combination with erlotinib (T+E) in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii496-viii497

2018

Volltextzugriff (PDF)

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors

Cancer medicine (Malden, MA), 2024-03, Vol.13 (5), p.n/a

2024

Volltextzugriff (PDF)

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

Journal of hepatology, 2024-05, Vol.80 (5), p.684-693

2024

Volltextzugriff (PDF)

P-48 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced pancreatic cancer

Annals of oncology, 2022-06, Vol.33, p.S263-S264

2022

Volltextzugriff (PDF)

Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort

Clinical infectious diseases, 2023-12, Vol.77 (12), p.1676-1686

2023

Volltextzugriff (PDF)

747P Phase I study of SAR444245 (SAR’245) as monotherapy (mono) and combined with pembrolizumab (pembro) or cetuximab (cetux) in patients (pts) with advanced solid tumors

Annals of oncology, 2022-09, Vol.33, p.S885-S886

2022

Volltextzugriff (PDF)

P-54 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer

Annals of oncology, 2022-06, Vol.33, p.S266

2022

Volltextzugriff (PDF)

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii736-viii736

2018

Volltextzugriff (PDF)

LBA24 KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation

Annals of oncology, 2022-09, Vol.33, p.S1391

2022

Volltextzugriff (PDF)

D100 LIGELIZUMAB ACHIEVES FAST CONTROL OF SYMPTOMS IN MORE PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA VERSUS OMALIZUMAB

Annals of allergy, asthma, & immunology, 2020-11, Vol.125 (5), p.S13-S13

2020

Volltextzugriff (PDF)

Blood transcriptomic comparison of individuals with and without autism spectrum disorder: A combined‐samples mega‐analysis

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2017-04, Vol.174 (3), p.181-201

2017

Volltextzugriff (PDF)

Association of Syndemic Unhealthy Alcohol Use, Cigarette Use, and Depression With All-Cause Mortality Among Adults Living With and Without HIV Infection: Veterans Aging Cohort Study

Open forum infectious diseases, 2019-06, Vol.6 (6), p.ofz188

2019

Volltextzugriff (PDF)

Phase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii451-viii452

2018

Volltextzugriff (PDF)

Oral tributyrin supplementation attenuates Alzheimer’s disease‐associated neuropathology and prevents cognitive and behavioral deficits in the 3xTg‐AD mouse model

Alzheimer's & dementia, 2023-12, Vol.19 (S13), p.n/a

2023

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(72)

Sprache

Englisch
(72)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Seckle's syndrome. (a case report)

Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice

Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation

MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study

Perceived Neighborhood Racial Composition and Depressive Symptoms Among Black Americans Across Adulthood: Evaluating the Role of Psychosocial Risks and Resources

Association of Syndemic Unhealthy Alcohol Use, Smoking, and Depressive Symptoms on Incident Cardiovascular Disease among Veterans With and Without HIV-Infection

Identifying the identifiers: How iNaturalist facilitates collaborative, research-relevant data generation and why it matters for biodiversity science

Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8)

An open-label, multicenter, phase I study of ABBV-399 (telisotuzumab vedotin, teliso-V) as monotherapy (T) and in combination with erlotinib (T+E) in non-small cell lung cancer (NSCLC)

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

P-48 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced pancreatic cancer

Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort

747P Phase I study of SAR444245 (SAR’245) as monotherapy (mono) and combined with pembrolizumab (pembro) or cetuximab (cetux) in patients (pts) with advanced solid tumors

P-54 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

LBA24 KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation

D100 LIGELIZUMAB ACHIEVES FAST CONTROL OF SYMPTOMS IN MORE PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA VERSUS OMALIZUMAB

Blood transcriptomic comparison of individuals with and without autism spectrum disorder: A combined‐samples mega‐analysis

Association of Syndemic Unhealthy Alcohol Use, Cigarette Use, and Depression With All-Cause Mortality Among Adults Living With and Without HIV Infection: Veterans Aging Cohort Study

Phase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy

Tributyrin oral administration significantly attenuates the loss of intestinal butyrate‐producing bacteria and the ensuing cognitive dysfunction associated with Alzheimer’s Disease pathogenesis in 3xTg‐AD mice

Oral tributyrin supplementation attenuates Alzheimer’s disease‐associated neuropathology and prevents cognitive and behavioral deficits in the 3xTg‐AD mouse model

Aktive Filter

Suchergebnisse filtern